Phytate Decreases Formation of Advanced Glycation End-Products in Patients With Type II Diabetes: Randomized Crossover Trial

Scientific Reports- United Kingdom

doi 10.1038/s41598-018-27853-9

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Serum Levels of Advanced Glycation End Products in Type II Diabetic Patients With Acute Cerebral Infarction

Biomedical Research
2018English

Advanced Glycation End Products, Fibroblast Growth Factors and the Development of Atherosclerosis in Patients With Diabetes

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2016English

Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus-Related Dementia

Journal of the American Geriatrics Society
GerontologyGeriatrics
2015English

Zinc Against Advanced Glycation End Products

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

Reduction of Advanced-Glycation End Products Levels and Inhibition of RAGE Signaling Decreases Rat Vascular Calcification Induced by Diabetes

PLoS ONE
Multidisciplinary
2014English

P40 Increased Advanced Glycation End Products in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Thorax
PulmonaryRespiratory Medicine
2011English

Pathophysiology of Advanced Glycation End-Products in Renal Failure

Nephrology Dialysis Transplantation
MedicineTransplantationNephrology
1996English

Correlation Between Advanced Glycation End-Products and the Expression of Fatty Inflammatory Factors in Type II Diabetic Cardiomyopathy

Bosnian Journal of Basic Medical Sciences
Medicine
2015English

Oxidative Stress in Diabetes – Circulating Advanced Glycation End Products, Lipid Oxidation and Vascular Disease

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy